Status:

COMPLETED

Association Between Hepatitis C Infection and Renal Cell Carcinoma

Lead Sponsor:

Henry Ford Health System

Collaborating Sponsors:

Schering-Plough

Conditions:

Hepatitis C

Renal Cell Carcinoma

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biops...

Eligibility Criteria

Inclusion

  • Male and female patients 18 years or older in whom renal cell carcinoma is suspected and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within 6 months.
  • Male and female patients 18 years or older in whom colorectal cancer has been diagnosed within the last 6 months

Exclusion

  • Patients who are unwilling to provide consent
  • Patients who decline to complete a questionnaire
  • Patient in who blood sample cannot be obtained
  • Diagnosis of renal cell carcinoma or colon cancer greater than 6 months

Key Trial Info

Start Date :

January 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2013

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT01405183

Start Date

January 1 2011

End Date

September 1 2013

Last Update

September 17 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Henry Ford Hospital

Detroit, Michigan, United States, 48202